J. Melville (“Mel”) Engle

Predictive Oncology Mel Engle

  (Eagan, MN) —  Sept. 16, 2022  — Predictive Oncology (NASDAQ: POAI) announced that J. Melville (“Mel”) Engle will retire as Chief Executive Officer and as Chairman and a member of the company’s Board of Directors. To ensure a smooth transition of his responsibilities, Mr. Engle will continue to serve in his role through October 31, 2022. Pursuant to policies regarding leadership succession, the governance committee of POAI’s Board of